SCHEMBL3259247

SCHEMBL3259247

Brc1cc2cc3cc4ccccc4cc3cc2cc1Br

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.50
ALDH1A1 P00352 6/20 0.48
HSD17B10 Q99714 4/20 0.48
HIF1A Q16665 3/20 0.48
TDP1 Q9NUW8 3/20 0.48
CYP3A4 P08684 2/20 0.48
CASP1 P29466 2/20 0.48
CASP7 P55210 2/20 0.48
ALOX15 P16050 1/20 0.48
HBB P68871 1/20 0.48
ALOX12 P18054 1/20 0.41
HPGD P15428 2/20 0.41
GLA P06280 1/20 0.41
MAPT P10636 1/20 0.41
ACHE P22303 1/20 0.41
NCEH1 Q6PIU2 1/20 0.39
NQO2 P16083 1/20 0.39
CYP1B1 Q16678 1/20 0.39
CYP1A2 P05177 2/20 0.38
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3465676 1.00 CYP2A6 (0.50) CYP2A6ALDH1A1HSD17B10HIF1ATDP1
SCHEMBL5008807 1.00 CYP2A6 (0.50) CYP2A6ALDH1A1HSD17B10HIF1ATDP1
SCHEMBL5010983 1.00 CYP2A6 (0.50) CYP2A6ALDH1A1HSD17B10HIF1ATDP1
SCHEMBL9097204 1.00 CYP2A6 (0.50) CYP2A6ALDH1A1HSD17B10HIF1ATDP1
SCHEMBL9095175 0.94 CYP2A6 (0.55) CYP2A6ALDH1A1HSD17B10HIF1ATDP1
SCHEMBL29374851 0.94 CYP2A6 (0.55) CYP2A6ALDH1A1HSD17B10HIF1ATDP1
Benz(B)Anthracene SCHEMBL7947 0.83 ALDH1A1 (0.61) CYP2A6ALDH1A1HSD17B10HIF1ATDP1
SCHEMBL25181 0.83 ALDH1A1 (0.61) CYP2A6ALDH1A1HSD17B10HIF1ATDP1
SCHEMBL22634171 0.83 ALDH1A1 (0.61) CYP2A6ALDH1A1HSD17B10HIF1ATDP1
Benz(B)Anthracene SCHEMBL22352910 0.83 ALDH1A1 (0.61) CYP2A6ALDH1A1HSD17B10HIF1ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7651746-B2 Halogenated bisdiarylaminopolycyclic aromatic compounds and polymers thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-01-26 US disclosed
US-20070126345-A1 Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-07 US disclosed
WO-2005049546-A1 HALOGENATED BISDIARYLAMINOPOLYCYLIC AROMATIC COMPOUNDS AND POLYMERS THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070126345-A1 Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof AHR, AADAC, ARNT CYP2A6 168/4885ALDH1A1 667/4885HSD17B10 951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.